Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Trojer

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Molecular Cell|May 21, 2011
L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structurePatrick Trojer, Alina R Cao, Zhonghua Gao, et al.
Cell|June 2, 2007
L3MBTL1, a histone-methylation-dependent chromatin lockPatrick Trojer, Guohong Li, Robert J Sims, et al.
Epigenetics & Chromatin|July 6, 2013
A quantitative atlas of histone modification signatures from human cancer cellsGary Leroy, Peter A Dimaggio, Eric Y Chan, et al.
The Journal of Clinical Investigation|June 16, 2018
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapySangeeta Goswami, Irina Apostolou, Jan Zhang, et al.
Cancer Research|February 4, 2016
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia SubtypesJohn P McGrath, Kaylyn E Williamson, Srividya Balasubramanian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2Christopher G Nasveschuk, Alexandre Gagnon, Shivani Garapaty-Rao, et al.
Cancer Research Communications|March 16, 2023
A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory LymphomaKristie A Blum, Jeffrey G Supko, Michael B Maris, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancerShipra Shukla, Dan Li, Holly Nguyen, et al.
Nature Cell Biology|May 17, 2020
Author Correction: Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesisDonglim Esther Park, Jingwei Cheng, John P McGrath, et al.
Nature Cell Biology|April 15, 2020
Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesisDonglim Esther Park, Jingwei Cheng, John P McGrath, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Molecular Cell|May 21, 2011
L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structurePatrick Trojer, Alina R Cao, Zhonghua Gao, et al.
Cell|June 2, 2007
L3MBTL1, a histone-methylation-dependent chromatin lockPatrick Trojer, Guohong Li, Robert J Sims, et al.
Epigenetics & Chromatin|July 6, 2013
A quantitative atlas of histone modification signatures from human cancer cellsGary Leroy, Peter A Dimaggio, Eric Y Chan, et al.
The Journal of Clinical Investigation|June 16, 2018
Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapySangeeta Goswami, Irina Apostolou, Jan Zhang, et al.
Cancer Research|February 4, 2016
Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia SubtypesJohn P McGrath, Kaylyn E Williamson, Srividya Balasubramanian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2Christopher G Nasveschuk, Alexandre Gagnon, Shivani Garapaty-Rao, et al.
Cancer Research Communications|March 16, 2023
A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory LymphomaKristie A Blum, Jeffrey G Supko, Michael B Maris, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
BET inhibitors as a therapeutic intervention in gastrointestinal gene signature-positive castration-resistant prostate cancerShipra Shukla, Dan Li, Holly Nguyen, et al.
Nature Cell Biology|May 17, 2020
Author Correction: Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesisDonglim Esther Park, Jingwei Cheng, John P McGrath, et al.
Nature Cell Biology|April 15, 2020
Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesisDonglim Esther Park, Jingwei Cheng, John P McGrath, et al.
Pageof 6